Insights
Clinical, CMC, and Regulatory Requirements for BLA Submission
Life sciences programs face evolving regulatory risks at every stage from preclinical IND filings to global CTA submissions and through NDA or BLA approvals. We
From Internal Audit to FDA Inspection: A GMP Readiness Checklist
For life sciences organizations, FDA inspections are high-stakes events that test every aspect of operations, from documentation and processes to staff readiness. Mock FDA audits
Remediation Planning for Pharma Companies
For medical device companies seeking to conduct clinical trials in the United States, an Investigational Device Exemption (IDE) application is essential. A well-prepared IDE submission
What FDA Looks for in IDE Submissions
For medical device innovators and biotechnology companies developing diagnostic or therapeutic devices, obtaining approval to begin clinical studies in the United States often requires an
FDA IDE Approval: Common Gaps and a Practical Checklist to Avoid Them
How Long Does FDA IDE Review Take? Key Milestones Explained For medical device innovators and biotechnology companies developing diagnostic or therapeutic devices, obtaining approval to
Pharmaceutical QMS Audit Failures
For biotech and pharmaceutical companies, regulatory inspections are not simply compliance events. They are a comprehensive evaluation of how an organization manages product quality, documentation,